Alteration of basic fibroblast growth factor expression in rat during cerebral ischemia

Acta Pharmacol Sin. 2000 Apr;21(4):296-300.

Abstract

Aim: To investigate the distribution and expression changes of basic fibroblast growth factor (bFGF)-like immunoreactivity (IR) in focal cerebral ischemic rat brain.

Methods: The expression of bFGF was observed by fluoro-immunohistochemistry. The focal cerebral ischemic injury was carried out using middle cerebral artery occlusion (MCAO) model.

Results: Confocal images demonstrated that both the striatum and the frontoparietal cortex showed increases of bFGF-like IR after 2-h MCAO and 24-h reperfusion. In striatum, the increase patterns of bFGF-like IR were different according to the ischemic extent. In the core of infarct and its surrounding region (with more IR induction), bFGF-like IR was mainly located in astrocytes. In region adjacent to infarct (with most IR induction, the grey ratio of bFGF-like IR increased from sham-98% +/- 10% to ischemia-125% +/- 6%), some neurons also showed an upregulation of bFGF-like IR. In frontoparietal cortex, strong induction of bFGF-like IR was mostly seen in neurons (The grey ratio of bFGF-like IR increased from sham-104% +/- 11% to ischemia-132% +/- 28%), although it was observed in astrocytes as well.

Conclusion: The expression of bFGF increased after focal cerebral ischemia in rats, suggesting that: in striatum, astrocytes may play an important role in the protection of neurons via the overexpression of bFGF; whereas in cortex, neurons probably exert an autoprotection through expressing bFGF themselves.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Astrocytes / metabolism
  • Brain Ischemia / metabolism*
  • Cerebral Cortex / metabolism
  • Corpus Striatum / metabolism
  • Fibroblast Growth Factor 2 / metabolism*
  • Infarction, Middle Cerebral Artery / metabolism*
  • Male
  • Microscopy, Confocal
  • Neurons / metabolism
  • Random Allocation
  • Rats
  • Rats, Sprague-Dawley

Substances

  • Fibroblast Growth Factor 2